KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Enterprise Value (2018 - 2025)

Twist Bioscience (TWST) has disclosed Enterprise Value for 6 consecutive years, with -$387.7 million as the latest value for Q1 2023.

  • On a quarterly basis, Enterprise Value rose 32.45% to -$387.7 million in Q1 2023 year-over-year; TTM through Sep 2023 was -$261.6 million, a 48.2% increase, with the full-year FY2022 number at -$505.0 million, down 11.1% from a year prior.
  • Enterprise Value was -$387.7 million for Q1 2023 at Twist Bioscience, down from -$316.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$77.1 million in Q4 2019 to a low of -$587.3 million in Q4 2020.
  • A 5-year average of -$310.3 million and a median of -$290.0 million in 2020 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: plummeted 661.97% in 2020, then surged 81.23% in 2021.
  • Twist Bioscience's Enterprise Value stood at -$77.1 million in 2019, then tumbled by 661.97% to -$587.3 million in 2020, then soared by 81.23% to -$110.2 million in 2021, then tumbled by 187.28% to -$316.7 million in 2022, then decreased by 22.41% to -$387.7 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Enterprise Value are -$387.7 million (Q1 2023), -$316.7 million (Q4 2022), and -$505.0 million (Q3 2022).